CU201

Known as: B9870 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2010
012320022010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Compound CU201 [SUIM-(d-Arg-Arg-Pro-Hyp-Gly-Igl-Ser-d-Igl-Oic-Arg)(2), where SUIM=suberimidyl; Hyp=trans-4-hydroxyproline; Igl… (More)
  • table 1
  • figure 2
  • figure 5
  • figure 7
  • table 4
Is this relevant?
2007
2007
BACKGROUND AND PURPOSE A bradykinin (BK) B2 receptor (B2R) antagonist, B-9870 (CU201), has been proposed to behave as a 'biased… (More)
Is this relevant?
2006
2006
G protein-coupled receptors (GPCR) and the epidermal growth factor receptor (EGFR) are often both overexpressed and contribute to… (More)
Is this relevant?
2002
2002
Bradykinin (BK) (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) is an important growth factor for small-cell lung cancer (SCLC) and… (More)
Is this relevant?
2002
2002
Small cell lung cancers (SCLCs), many non-SCLCs, and other cancers have neuroendocrine features, including paracrineand autocrine… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2002
2002
All small cell (SCLCs) and many non-small cell lung cancers (NSCLCs) have neuroendocrine features including production of… (More)
  • table 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?